about
Cystic Fibrosis and the Nervous System.Drug-induced dyspnea versus cystic fibrosis exacerbation: a diagnostic dilemma.The safety of lumacaftor and ivacaftor for the treatment of cystic fibrosis.Medical and Surgical Advancements in the Management of Cystic Fibrosis Chronic Rhinosinusitis.Matrine in association with FD‑2 stimulates F508del‑cystic fibrosis transmembrane conductance regulator activity in the presence of corrector VX809.Advancing precision medicine for the treatment of long-QT syndrome type 2: shedding light on lumacaftor.Identification of a targeted and testable antiarrhythmic therapy for long-QT syndrome type 2 using a patient-specific cellular model.New Approaches to Difficult Drug Targets: The Phosphatase Story
P2860
Q39017146-65AA7040-A523-4292-BF75-6A91CAF18854Q41138186-AE2D1C8D-74E5-400B-848C-3EC08F945077Q47897974-5122E470-67BB-433D-B822-919FDB7F9418Q49490627-A16530AB-D3D7-474F-AA9A-943B3D071F72Q49641292-F5035D6D-3BCC-4583-B065-AEA293E5E8EDQ50080496-AE3217AD-802A-4DA4-875E-8E8E081FCCF0Q50094161-186AE47D-748E-41BF-9287-CA26BE1747A1Q56513340-14175DE6-3D49-46A9-8E30-AE06DF4EE752
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Lumacaftor/Ivacaftor: A Review in Cystic Fibrosis.
@en
type
label
Lumacaftor/Ivacaftor: A Review in Cystic Fibrosis.
@en
prefLabel
Lumacaftor/Ivacaftor: A Review in Cystic Fibrosis.
@en
P2860
P1433
P1476
Lumacaftor/Ivacaftor: A Review in Cystic Fibrosis.
@en
P2093
Emma D Deeks
P2860
P2888
P304
P356
10.1007/S40265-016-0611-2
P577
2016-07-09T00:00:00Z
P6179
1053082139